🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 18 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/10/2006 28,92 29,10 25,86 26,52 -8,30% 11,20% 268.533
23/10/2006 26,10 29,34 25,32 28,92 +10,30% 15,40% 348.867
20/10/2006 24,54 26,22 24,42 26,22 +7,37% 7,33% 324.600
19/10/2006 23,46 25,08 22,68 24,42 +8,82% 10,23% 402.067
18/10/2006 23,52 23,52 22,14 22,44 -3,11% 5,87% 67.450
17/10/2006 22,98 23,16 21,78 23,16 +0,26% 6,01% 133.267
16/10/2006 22,86 23,40 22,68 23,10 +0,79% 3,15% 108.550
13/10/2006 22,86 23,10 22,62 22,92 -0,52% 2,10% 56.067
12/10/2006 22,68 23,10 22,44 23,04 +2,67% 2,91% 71.183
11/10/2006 23,16 23,16 22,44 22,44 -3,11% 3,11% 44.033
10/10/2006 22,86 23,28 22,14 23,16 +1,05% 4,99% 74.117
09/10/2006 22,68 23,70 22,44 22,92 +1,33% 5,56% 124.633
06/10/2006 21,90 22,74 21,06 22,62 +5,90% 7,67% 139.850
05/10/2006 18,90 21,90 18,60 21,36 +11,95% 17,46% 134.933
04/10/2006 20,10 20,22 17,70 19,08 -7,29% 12,54% 249.083
03/10/2006 20,82 20,94 20,52 20,58 -2,28% 2,02% 39.533
02/10/2006 21,66 21,72 20,70 21,06 -3,57% 4,71% 57.467
29/09/2006 22,32 23,28 21,36 21,84 +3,41% 8,60% 197.483
28/09/2006 21,72 21,96 20,70 21,12 -1,95% 5,80% 116.350
27/09/2006 20,70 21,96 20,70 21,54 +3,16% 6,09% 40.417
26/09/2006 20,58 21,24 20,58 20,88 +1,46% 3,21% 31.183
25/09/2006 21,36 21,72 20,34 20,58 -4,19% 6,46% 88.783
22/09/2006 21,90 22,14 21,24 21,48 -2,72% 4,11% 45.417
21/09/2006 21,96 22,38 21,66 22,08 +1,38% 3,28% 44.350
20/09/2006 21,60 22,50 21,54 21,78 +1,11% 4,44% 40.250
19/09/2006 22,50 22,50 21,18 21,54 -2,45% 5,87% 51.800
18/09/2006 21,60 22,20 21,06 22,08 +2,22% 5,28% 48.233
15/09/2006 21,60 21,72 21,42 21,60 +1,12% 1,39% 63.833
14/09/2006 21,78 21,78 21,18 21,36 -1,93% 2,75% 59.817
13/09/2006 21,36 22,14 21,06 21,78 +2,25% 5,06% 48.300